Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074507
Filing Date
2011-08-08
Accepted
2011-08-08 17:22:06
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b82762e10vq.htm 10-Q 856963
2 EX-10.3 b82762exv10w3.htm EX-10.3 21055
3 EX-31.1 b82762exv31w1.htm EX-31.1 5759
4 EX-31.2 b82762exv31w2.htm EX-31.2 5991
5 EX-32.1 b82762exv32w1.htm EX-32.1 4461
12 GRAPHIC b82762b8276206.gif GRAPHIC 2466
  Complete submission text file 0000950123-11-074507.txt   11897880

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT alr-20110630.xml EX-101.INS 2380171
7 EX-101 SCHEMA DOCUMENT alr-20110630.xsd EX-101.SCH 71633
8 EX-101 CALCULATION LINKBASE DOCUMENT alr-20110630_cal.xml EX-101.CAL 133386
9 EX-101 LABELS LINKBASE DOCUMENT alr-20110630_lab.xml EX-101.LAB 579467
10 EX-101 PRESENTATION LINKBASE DOCUMENT alr-20110630_pre.xml EX-101.PRE 481539
11 EX-101 DEFINITION LINKBASE DOCUMENT alr-20110630_def.xml EX-101.DEF 326392
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
ALERE INC. (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16789 | Film No.: 111018104
SIC: 2835 In Vitro & In Vivo Diagnostic Substances